A detailed history of Jane Street Group, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 189,792 shares of TXG stock, worth $3.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
189,792
Previous 14,854 1177.72%
Holding current value
$3.01 Million
Previous $557,000 562.66%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$19.45 - $37.37 $3.4 Million - $6.54 Million
174,938 Added 1177.72%
189,792 $3.69 Million
Q1 2024

May 15, 2024

SELL
$36.08 - $54.3 $2.04 Million - $3.07 Million
-56,597 Reduced 79.21%
14,854 $557,000
Q4 2023

Feb 14, 2024

BUY
$34.32 - $57.55 $1.73 Million - $2.91 Million
50,548 Added 241.82%
71,451 $4 Million
Q3 2023

Nov 14, 2023

SELL
$40.86 - $62.98 $2 Million - $3.09 Million
-49,012 Reduced 70.1%
20,903 $862,000
Q2 2023

Aug 14, 2023

BUY
$50.96 - $58.72 $438,459 - $505,226
8,604 Added 14.03%
69,915 $3.9 Million
Q1 2023

May 15, 2023

SELL
$35.33 - $55.79 $230,280 - $363,639
-6,518 Reduced 9.61%
61,311 $3.42 Million
Q4 2022

Feb 14, 2023

BUY
$24.4 - $41.3 $1.04 Million - $1.77 Million
42,816 Added 171.17%
67,829 $2.47 Million
Q3 2022

Nov 14, 2022

SELL
$28.48 - $52.59 $170,111 - $314,120
-5,973 Reduced 19.28%
25,013 $712,000
Q2 2022

Aug 16, 2022

BUY
$36.95 - $82.41 $574,683 - $1.28 Million
15,553 Added 100.78%
30,986 $1.4 Million
Q4 2021

Feb 15, 2022

SELL
$135.05 - $182.59 $67,254 - $90,929
-498 Reduced 3.13%
15,433 $2.3 Million
Q3 2021

Nov 16, 2021

SELL
$145.58 - $192.14 $3.16 Million - $4.17 Million
-21,700 Reduced 57.67%
15,931 $2.32 Million
Q2 2021

Aug 16, 2021

BUY
$134.22 - $202.37 $1.77 Million - $2.67 Million
13,214 Added 54.12%
37,631 $7.37 Million
Q1 2021

May 18, 2021

SELL
$140.25 - $196.86 $723,830 - $1.02 Million
-5,161 Reduced 17.45%
24,417 $4.42 Million
Q4 2020

Feb 17, 2021

SELL
$126.47 - $163.7 $11.2 Million - $14.5 Million
-88,626 Reduced 74.98%
29,578 $4.19 Million
Q3 2020

Nov 17, 2020

BUY
$87.44 - $125.0 $10.1 Million - $14.5 Million
115,656 Added 4539.09%
118,204 $14.7 Million
Q2 2020

Aug 17, 2020

SELL
$58.39 - $89.31 $2.09 Million - $3.19 Million
-35,718 Reduced 93.34%
2,548 $228,000
Q1 2020

May 15, 2020

BUY
$51.57 - $106.62 $1.97 Million - $4.08 Million
38,266 New
38,266 $2.39 Million
Q4 2019

Feb 14, 2020

SELL
$46.07 - $79.54 $462,865 - $799,138
-10,047 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$49.99 - $62.0 $502,249 - $622,914
10,047 New
10,047 $506,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.51B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.